Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](PharmaEssentia)"
Count: 25
Selected: 0
NCT IDTitle
NCT05245578Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects
NCT05231044A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp
NCT03546465Safety, Tolerability, Pharmacokinetics & Pharmacodynamics Study of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects
NCT05522816KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis
NCT05485948A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU
NCT05482971A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET
NCT05481151A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
NCT05129644Single Dose Escalation Study of P1101 in Healthy Adult Male Subjects
NCT04774107The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection
NCT04638439The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection
NCT04382937Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection
NCT04285086Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
NCT01587586Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection
NCT04655092Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
NCT04182100Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply
NCT05494528Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue Therapy
NCT05467553A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection
NCT04233840P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma
NCT04168957An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007
NCT03165955A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients
NCT01949805Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera
NCT02218047AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
NCT02523638Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients
NCT04035473A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel
NCT04180384A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients